<DOC>
	<DOCNO>NCT02197364</DOCNO>
	<brief_summary>The purpose study evaluate significance KL-6 biomarker clinical diagnosis interstitial lung disease ( ILD ) detect serum KL-6 level among patient ILD , compare clinical diagnostic criterion respiratory disease . In addition , study discus value KL-6 level term ILD treatment effect evaluation detection serum KL-6 level treatment treatment .</brief_summary>
	<brief_title>The Role KL-6 Clinical Diagnosis ILD</brief_title>
	<detailed_description>As multi-center , double-blind clinical study , trial divide two part . Part 1 : The purpose part evaluate role KL-6 biomarker clinical diagnosis interstitial lung disease ( ILD ) detect serum KL-6 level among patient ILD , compare clinical diagnostic criterion respiratory disease , include pulmonary tuberculosis , pneumonia , bronchiectasis , chronic obstructive pulmonary disease healthy control group . Part 2 : The purpose part study value KL-6 level term ILD treatment effect evaluation detection serum KL-6 level treatment 30-90 day treatment . Treatment include anti fibrosis , anti-inflammatory conventional therapy .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Interstitial</mesh_term>
	<criteria>Serums patient ILD , pulmonary tuberculosis , pneumonia , bronchiectasis , chronic obstructive pulmonary disease health Serums patient ILD : treatment 3090 day treatment Serums patient cancer Serums visible precipitate Serums floc</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Interstitial Lung Disease</keyword>
	<keyword>Diagnosis</keyword>
	<keyword>Krebs Von Den Lungen-6</keyword>
</DOC>